Skip to content

A prospective, multicenter, randomized, open, positive control, non-inferiority clinical trial was conducted to evaluate the efficacy and safety of rigid gas permeable contact lenses for the temporary correction of myopia in orthokeratology

A prospective, multicenter, randomized, open, positive control, non-inferiority clinical trial was conducted to evaluate the efficacy and safety of rigid gas permeable contact lenses for the temporary correction of myopia in orthokeratology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073018
Enrollment
Unknown
Registered
2023-06-29
Start date
2022-03-22
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

experimental group:Wear orthokeratology lenses (Mode: Ortholens)

Sponsors

Eye Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
8 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Age =8 weeks old, both sexes; 2. The contact lens diopter of both eyes of the patients was within the applicable parameters of the study lenses (myopic diopter between -0.50D and -4.00D (including -0.50D and -4.00D astigmatism diopter within 1.50D (including 1.50D) 3. Able to complete 12 months of follow-up; 4. Able to understand the purpose of the trial, voluntarily participate in the study, and informed consent was signed by the subject himself or his legal guardian. Note: Minors aged 8 years or older but under 18 years old should be subject to informed consent from themselves and their guardians Informed consent was signed. Adults over 18 years old as subjects should obtain their own informed consent and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. One eye met the inclusion criteria; 2. Immunocompromised patients with systemic diseases or orthokeratology (e.g. previous diabetes mellitus) Disease, Down syndrome, rheumatoid arthritis, mental illness, etc., with acute and chronic sinuses within 1 year Inflammation and so on 3. Patients with corneal abnormalities, previous corneal surgery or a history of corneal trauma or decreased corneal sensation 4. The following ocular conditions are present: Acute anterior segment Subacute or chronic inflammation or infection; Any eye condition, injury, or structural abnormality that affects the cornea, conjunctiva, or eyelids (e.g., dacryocystitis, acute conjunctivitis, blepharitis and other inflammations, glaucoma, etc. Dry eye (TBUT=2 seconds Active bacterial, fungal, viral, and other corneal infections Pathological redness or redness of the eyes. 5. Patients with best corrected distance visual acuity less than fractional visual acuity 1.0; 6. Patients with refractive instability; 7. Patients with irregular corneal astigmatism; 8. Patients with overt strabismus; 9. Abnormal intraocular pressure (The normal range of intraocular pressure is 10-21 mmHg, the difference in intraocular pressure between the two eyes should be less than 5 mmHg; 10. Patients with corneal endothelial cell density less than 2000 cells /mm2; 11. Patients who have worn orthokeratology lenses within the past 30 days; 12. Patients with a history of allergy to contact lenses or contact lens solution; 13. Medications that may cause dry eye or affect vision and corneal curvature are being used or required during the study (immunosuppressant, glucocorticoid, intraocular pressure lowering drugs, etc.) 14. Enrollment in other drug clinical trials within 3 months before screening, and enrollment in other medical device clinical trials within 30 days before screening; 15. Pregnant, lactating or planning to become pregnant in the near future; 16. Unable to follow doctor's advice; 17. Unable to understand the limitations and reversibility of orthokeratology for myopia; 18. Findings suggest other contraindications to wear (e.g., significant fluorescent staining of the corneal epithelium or inappropriate fitting of the orthokeratology lenses); 19. Other circumstances in which the patient was judged by the investigator to be ineligible.

Design outcomes

Primary

MeasureTime frame
Uncorrected visual acuity;Residual diopter;

Secondary

MeasureTime frame
Uncorrected visual acuity;Product efficiency when wearing glasses for 30 days;Diopter;

Countries

China

Contacts

Public ContactJun Jiang

Eye Hospital, Wenzhou Medical University

jjhsj@hotmail.com+86 135 0651 1080

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026